Caeser, Rebecca
Gao, Jie
Di Re, Miriam
Gong, Chun
Hodson, Daniel J. http://orcid.org/0000-0001-6225-2033
Funding for this research was provided by:
Cancer Research UK (A25117, A25117, A25117, A25117)
Wellcome Trust (203151/Z/16/Z, 203151/Z/16/Z, 203151/Z/16/Z, 203151/Z/16/Z, 203151/Z/16/Z)
Article History
Received: 4 March 2020
Accepted: 21 January 2021
First Online: 9 April 2021
Competing interests
: R.C.: consultancy for Karus Therapeutics. D.H.: research funding from Gilead Sciences. The remaining authors declare no competing interests.